These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14637138)

  • 1. A new human peptide deformylase inhibitable by actinonin.
    Lee MD; Antczak C; Li Y; Sirotnak FM; Bornmann WG; Scheinberg DA
    Biochem Biophys Res Commun; 2003 Dec; 312(2):309-15. PubMed ID: 14637138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
    Lee MD; She Y; Soskis MJ; Borella CP; Gardner JR; Hayes PA; Dy BM; Heaney ML; Philips MR; Bornmann WG; Sirotnak FM; Scheinberg DA
    J Clin Invest; 2004 Oct; 114(8):1107-16. PubMed ID: 15489958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.
    Hu L; Cai X; Dong S; Zhen Y; Hu J; Wang S; Jiang J; Huang J; Han Y; Qian Y; Yuan Y; Hu W
    J Med Chem; 2020 Jul; 63(13):6959-6978. PubMed ID: 32551649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human mitochondrial peptide deformylase causes apoptosis in c-myc-overexpressing hematopoietic cancers.
    Sheth A; Escobar-Alvarez S; Gardner J; Ran L; Heaney ML; Scheinberg DA
    Cell Death Dis; 2014 Mar; 5(3):e1152. PubMed ID: 24675470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide deformylases from Vibrio parahaemolyticus phage and bacteria display similar deformylase activity and inhibitor binding clefts.
    Grzela R; Nusbaum J; Fieulaine S; Lavecchia F; Desmadril M; Nhiri N; Van Dorsselaer A; Cianferani S; Jacquet E; Meinnel T; Giglione C
    Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):348-355. PubMed ID: 29101077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and activity of human mitochondrial peptide deformylase, a novel cancer target.
    Escobar-Alvarez S; Goldgur Y; Yang G; Ouerfelli O; Li Y; Scheinberg DA
    J Mol Biol; 2009 Apr; 387(5):1211-28. PubMed ID: 19236878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer.
    Gao J; Wang T; Qiu S; Zhu Y; Liang L; Zheng Y
    Molecules; 2016 Mar; 21(4):396. PubMed ID: 27023495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carboxy-terminal end of the peptide deformylase from Mycobacterium tuberculosis is indispensable for its enzymatic activity.
    Saxena R; Chakraborti PK
    Biochem Biophys Res Commun; 2005 Jul; 332(2):418-25. PubMed ID: 15896710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets.
    Wang Q; Zhang D; Wang J; Cai Z; Xu W
    Biophys Chem; 2006 Jun; 122(1):43-9. PubMed ID: 16545516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
    Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
    Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human peptide deformylase disrupts mitochondrial function.
    Escobar-Alvarez S; Gardner J; Sheth A; Manfredi G; Yang G; Ouerfelli O; Heaney ML; Scheinberg DA
    Mol Cell Biol; 2010 Nov; 30(21):5099-109. PubMed ID: 20805355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
    Antczak C; Shum D; Bassit B; Frattini MG; Li Y; de Stanchina E; Scheinberg DA; Djaballah H
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4528-32. PubMed ID: 21719286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.
    Guilloteau JP; Mathieu M; Giglione C; Blanc V; Dupuy A; Chevrier M; Gil P; Famechon A; Meinnel T; Mikol V
    J Mol Biol; 2002 Jul; 320(5):951-62. PubMed ID: 12126617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analyses and inhibition studies reveal novel features in peptide deformylase 1 from Trypanosoma cruzi.
    Rodrígues-Poveda CA; Pérez-Moreno G; Vidal AE; Urbina JA; González-Pacanowska D; Ruiz-Pérez LM
    Mol Biochem Parasitol; 2012; 182(1-2):83-7. PubMed ID: 22209909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioselectivity in inhibition of peptide deformylase from Haemophilus influenzae by 4- vs 5-azaindole hydroxamic acid derivatives: Biochemical, structural and antimicrobial studies.
    Reddi B; Kishor C; Jangam A; Bala S; Rajeswari Batchu U; Gundla R; Addlagatta A
    Bioorg Chem; 2022 Nov; 128():106095. PubMed ID: 36049321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
    Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H, 13C and 15N NMR assignments of the E. coli peptide deformylase in complex with a natural inhibitor called actinonin.
    Larue V; Seijo B; Tisne C; Dardel F
    Biomol NMR Assign; 2009 Jun; 3(1):153-5. PubMed ID: 19636969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.